- Home
- ALM vs DNTH Comparison
ALM vs DNTH Comparison
Compare ALM & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALM | DNTH |
|---|---|---|
| Founded | N/A | 2015 |
| Country | United States | United States |
| Employees | 342 | N/A |
| Industry | Other Metals and Minerals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.5B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | ALM | DNTH |
|---|---|---|
| Price | $14.89 | $97.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 13 |
| Target Price | $22.33 | ★ $121.00 |
| AVG Volume (30 Days) | ★ 4.9M | 1.2M |
| Earning Date | 05-20-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,036,000.00 |
| Revenue This Year | $817.94 | N/A |
| Revenue Next Year | $158.05 | $29.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.16 | $18.08 |
| 52 Week High | $24.41 | $102.33 |
Technical Indicators
Market Signals| Indicator | ALM | DNTH |
|---|---|---|
| Relative Strength Index (RSI) | 41.56 | 61.09 |
| Support Level | $14.70 | $79.27 |
| Resistance Level | $20.59 | N/A |
| Average True Range (ATR) | 1.23 | 5.38 |
| MACD | -0.05 | 0.77 |
| Stochastic Oscillator | 18.74 | 77.66 |
Price Performance
Historical ComparisonAbout ALM Almonty Industries Inc.
Almonty Industries Inc is engaged in the development of the Sangdong Mine in South Korea, and the Company is currently mining, processing, and shipping tungsten concentrate from the Panasqueira tin and tungsten mine in Covilha, Castelo Branco, Portugal (Panasqueira Mine). Additionally, the Company is evaluating its molybdenum project with inferred mineral resources on a separate property adjacent to the tungsten orebody at the Sangdong Mine, its Valtreixal tin and tungsten mine project located in Western Spain in the province of Zamora (Valtreixal Mine), and the newly-acquired Gentung Browns Lake tungsten project located in Montana, USA (Gentung-Browns Lake Project). The company has two geographical locations: the Iberian Peninsula (Spain and Portugal) and the Republic of Korea.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.